Home » Newsletters » BioWorld Science

BioWorld Science

May 30, 2007

View Archived Issues

Promising preclinical results of novel Yellow fever virus vaccine

Recombinant CD outer membrane protein is a promising vaccine candidate against Moraxella infection

Promising preclinical results of novel gene therapy against Niemann-Pick disease

Preclinical snapshots of the 68th Annual Meeting of the Society for Investigative Dermatology

Preclinical studies presented at ECTS

Basic research on novel drugs reported at the 103rd ATS conference

Novel therapeutic agents for neurological disorders disclosed in recent patents

Kitasato Institute and Aphoenix patent novel compounds for colitis

Data presented on p16INK4a biomarker for cervical dysplasia

BG Medicine and M.D. Anderson collaborate on breast cancer biomarkers

Recent patents disclose novel antipsychotic and anxiolytic agents

In vitro results of UK-500,001, Pfizer's novel PDE4 inhibitor for the treatment of COPD

EpiStem begins biomarker feasibility studies with AstraZeneca

VR1 antagonist GRC-6211 completes phase I trials in Europe

Recent patents describe new therapeutic agents for diabetes

Further clinical data on ambrisentan in pulmonary hypertension presented

Japanese approval for omeprazole 10 mg in nonerosive GERD

Bionomics selects BNC-210 as drug candidate for psychiatric disorders

New trial explores Reolysin with paclitaxel and carboplatin in advanced cancers

SD-118 begins phase I trials for neuropathic pain

Advisory Committee meeting set to review of Tysabri for Crohn's disease

Swissmedic grants accelerated assessment of planned application for ceftobiprole

FDA approval for Xyzal

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...